OMB's AI acquisition memo asks agencies to check new AI features before they go live. That check needs a named owner and a deadline.
Section 1557 gives covered hospitals an ongoing duty to identify and mitigate discrimination risk in clinical decision support tools. Finding the tool is the easy part.
The only secure AI is the one that never leaves your network.
DataSecurity
+3
Revised Fed, OCC and FDIC guidance recognizes that a model may need to go into use before validation is finished, with limits. Someone has to own that call.
The new interagency model risk guidance leaves generative and agentic AI out of scope. Banks still own the risk.
FDA's draft guidance on AI in drug development turns model credibility into a decision someone has to own.
The NAIC model bulletin asks insurers to govern AI systems that support regulated decisions. Governance that waits is still a wait.
ABA Formal Opinion 512 put generative AI under the rules lawyers already follow. The slow part is deciding who answers.
CMMC Phase 1 makes a current status in SPRS a condition of award. The last step is a person.
